Matthew E. Nielsen, MD


Smith AB, Horvath-Puho E, Nielsen ME, Lash TL, Baron JA and Sorensen HT (2014).  Effect of comorbidity on risk of venous thromboembolism in patients with renal cell carcinoma, Urol Oncol 32(4):466-72. PMID: 24767684

Selph JP, Whited WM, Smith AB, Matthews J, Pruthi RS, Wallen EM, Nielsen ME and Woods ME (2014). Metabolic syndrome as a predictor for postoperative complications following urologic surgery.  Urology 83(5):1051-9. PMID: 24656508

Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Nielsen ME and Rathmell WK (2014).  ClearCode34: a prognostic risk predictor for clear cell renal cell carcinoma. Eur Urol. 66(1): 77-84. PMID: 24613583

Song L, Ji Y, Knafl G and Nielsen ME (2014).  Quality of life and health status among prostate cancer survivors and non-cancer population controls.  Urology 83(3): 658-63. 

Chen RC, Hendrix LH, Carpenter WR, Bainbridge J, Wang ZA, Nielsen ME and Godley PA (2014).  Receipt of guideline-concordant treatment in elderly prostate cancer patients. Int J Radiat Oncol Biol Phys 88(2): 332-8.  PMID: 24411605

Smith AB, Yu H, Deal AM, Muss HB, Matthews J and Nielsen ME (2014).  Sarcopenia as a predictor for complications and survival following radical cystectomy.  J Urol  [Epub ahead of print]   PMID: 24423437

Smith AB, Deal AM, Woods ME, Wallen EM, Pruthi RS, Chen RC, Milowsky MI and Nielsen ME (2013).  Muscle-invasive bladder cancer: Evaluating treatment and survival in the National Cancer Data Base.  BJU International.  [Epub ahead of print] PMID: 24325202

Johnson DC, Nielsen ME, Matthews J, Woods ME, Wallen EM, Pruthi RS, Milowsky MI  and Smith AB (2013).  Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity.  BJU International.  [Epub ahead of print] PMID: 24274722

Nielsen ME, Mallin K, Weaver MA, Palis B, Stewart A, Winchester DP and Milowsky MI (2013).  The association of hospital volume with conditional 90-day mortality after cystectomy: An analysis of the National Cancer Database.  In press, BJU International.  114(1): 46-55. PMID: 24219110

Nielsen ME, Smith AB, Meyer AM, Kuo TM, Tyree S, Kim WY, Milowsky MI, Pruthi RS and Millikan R (2014).  Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988-2006.   Cancer 120(1): 86-95. PMID: 24122346

Langston JP, Kirby EW, Nielsen ME, Smith AB, Woods ME, Wallen EM and Pruthi RS (2014).  Economic impact of career choices in urology.  J Urol.  191(3):755-60. PMID: 24096119

Howard K, Brenner A, Lewis C, Sheridan S, Crutchfield T, Hawley S, Nielsen ME and Pignone MP (2013).  A comparison of US and Australian men’s values and preferences for PSA screening.   BMC Health Services Research  13(1): 388. PMID: 24093428

Olshan AO, Kuo TM, Meyer AM, Nielsen ME, Purdue MP and Rathmell WK (2013).  Racial difference in histologic subtype of renal cell carcinoma.  Cancer Medicine 2(5):744-9.   PMID: 24403240

Trantham LC, Nielsen ME, Mobley LR, Wheeler SB, Carpenter WR and Biddle AK (2013).  Use of prostate-specific antigen testing as a disease surveillance tool following radical prostatectomy.  Cancer 119(19): 3523-30.  PMID: 23893821

Smith AB, Woods ME, Raynor MC, Nielsen ME, Wallen EM and Pruthi RS (2013).  Prevention and management of complications following robot-assisted radical cystectomy: lessons learned after >250 consecutive cases.  World J Urol 31(3): 441-6.  PMID: 23269587

Zhang Y, Denton BT and Nielsen ME (2013).  Comparison of surveillance strategies for low risk bladder cancer patients.  Medical Decision Making;33(2):198-214.  PMID: 23178638

Smaldone MC, Simhan J, Kutikov A, Canter DJ, Starkey R, Zhu F, Nielsen ME, Stitzenberg KB, Greenberg RE and Uzzo RG (2013).  Trends in regionalization of radical cystectomy in three large Northeastern states from 1996-2009.  Urol Oncol 31(8): 1663-9.  PMID: 22687566

Mmeje CO, Nunez-Nateras R, Nielsen ME, Pruthi RS, Smith A, Wallen EM, Humphreys MR, Woods ME and Castle EP (2012).  Oncologic outcomes for lymph-node positive urothelial carcinoma patients treated with robot-assisted radical cystectomy with mean follow-up of 3.5 years.  Urol Oncol 31(8): 1621-7. PMID: 22534088

Raynor MC, Lavien G, Nielsen M, Wallen EM and Pruthi RS (2013).  Elimination of preoperative mechanical bowel preparation in patients undergoing cystectomy and urinary diversion.  Urol Oncol 31(1): 32-5. PMID: 21719323

Song L, Chen RC, Bensen JT, Knafl GJ, Nielsen ME, Farnan L, Wallen EM, Mishel M, Pruthi RS, Mohler JL, Godley PA.  Who makes the decision regarding the treatment of clinically localized prostate cancer - the patient of physician?  Results from a population-based study.  Cancer, 2012 Jul 11.  doi:  10.1002/cncr.277738.  Epub ahead of print.

Mmeje CO, Nunez-Nateras R, Nielsen ME, Pruthi RS, Smith A, Wallen EM, Humphreys MR, Woods ME, Castle EP.  Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy:  With mean follow-up of 3.5 years.  Urol Oncol, 2012 Apr 23.  Epub ahead of print.

Nielsen ME, Smith AB, Pruthi RS, Guzzo TJ, Amiel G, Shore N, Lotan Y.  Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC):  results from the Bladder Cancer Advocacy Network (BCAN) survey.  BJU Int, 2012 Apr 4.  doi:  10.1111/j.1464-410X.2012.11060.x.  Epub ahead of print.

Ferguson JE, Goyal RK, Raynor MC, Nielsen ME, Pruthi RS, Brown PM, Wallen EM.  Cost analysis of robot-assisted laparoscopic versus hand-assisted laparoscopic partial nephrectomy.  J Endourol, 2012 Apr 26.  Epub ahead of print.

Smith AB, Raynor M, Amling CL, Busby JE, Castle E, Davis R, Nielsen ME, Thomas R, Wallen EM, Woods M, Pruthi RS.  Multi-institutional analysis of robotic radical cystectomy for bladder cancer:  Perioperative outcomes and complications in 277 patients.  J Laparoendosc Adv Surg Tech A, 2011 Dec 5.  Epub ahead of print.

Lotan Y, Amiel G, Boorjian SA, Clark PE, Droller M, Gingrich JR, Guzzo TJ, Inman BA, Kamat AM, Karsh L, Nielsen ME, et al.  Comprehensive handbook for developing a bladder cancer cystectomy database.  On Behalf of the Bladder Cancer Think Tank and Bladder Cancer Advocacy Network.  Urol Oncol, 2011 Nov 4.  Epub ahead of print.

Brannon AR, Haake SM, Hacker KE, Pruthi RS, Wallen EM, Nielsen ME, Rathmell WK.  Meta-analysis of clear cell renal cell carcinoma gene expressin defines a variant subgroup and identifies gender influences on tumor biology.  Eur Urol, 2012 Feb;61(2):258-68.  Epub 2011 Oct 18.

Manvar AM, Rathmell WK, Ferguson J, Pruthi RS, Nielsen ME, Wallen EM, Nolan N, Raynor MC.  Carcinoma in a cadaveric transplant kidney.  Urology, 2011 Oct 18.  Epub ahead of print.

Raynor MC, Lavien G, Nielsen ME, Wallen EM, Pruthi RS.  Elimination of preoperative mechanical bowel preparation in patients undergoing cystectomy and urinary diversion.  Urol Oncol, 2011 Jun 28.  Epub ahead of print.

Stitzenberg B, Wong YN, Nielsen ME, Egleston BL, Uzzo RG.  Trends in radical prostatectomy:  centralization, robotics, and access to urologic cancer care.  Cancer, 2012 Jan 1;118(1):54-62.  doi: 10.1002/cncr.26274.  Eputb 2011 June 29.

Nielsen ME.  Editorial Comment.  J Urol, 2011 Aug:186(2):493.  Epub 2011 June 15.

Coward RM, Smith A, Raynor M, Nielsen ME, Wallen EM, Pruthi RS.  Feasibility and outocmes of robotic-assisted laparoscopic radical cystectomy for bladder cancer in older patients.  Urology, 2011 May;77(5):1111-4.  Epub 2011 Feb 18.

Manvar AM, Wallen EM, Pruthi RS, Nielsen ME.  Prognostic value of CA 125 in transitional cell carcinoma of the bladder.  Expert Rev Anticancer Ther, 2010 Dec:10(12):1877-81.

Schultz L, Albadine R, Hicks J, Jadallah S, DeMarzo AM, Chen YB, Nielsen ME, et al.  Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy.  Cancer, 2010 Dec1:116(23):5517-26.  doi: 10.1002/cncr.22502.  Epub 2010 Oct 11.

Brannon AR, Reddy A, Seiler M, Arreola A, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, et al.  Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns.  Genes Cancer, 2010 Feb 1:1(2):152-163.

Nielsen ME.  Use and misuse of imaging by urologists.  J Urol, 2010 Jul:184(1):12-4.  Epub 2010 May 15.

Makarov DV, Loeb S, Landman AB, Nielsen ME, et al.  Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database.  J Urol, 2010 Apr:183(4):1504-9.  Epub 2010 Feb 20.

Cowey CL, Amin C, Pruthi RS, Wallen EM, Nielsen ME, et al.  Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma.  J Clin Oncol, 2010 Mar 20:28(9):1502-7.  Epub 2010 Feb 16.

Nielsen ME, Trock BJ, Walsh PC.  Salvage or adjuvant radiation therapy:  Counseling patients on the benefits.  J Natl Compr Canc Netw, 2010 Feb:8(2):228-37.  Review.

Pruthi RS, Nielsen ME, Smith A, Nix J, Schultz H, Wallen EM.  Fast track program in patients undergoing radical cystectomy:  Results in 362 consecutive patients.  J Am Coll Surg, 2010 Jan:210(1):93-9.  Epub 2009 Oct 28.

Pruthi RS, Nielsen ME, Heathcote S, Wallen EM, Rathmell WK, et al.  A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy:  Clinical and pathological results.  BJU Int, 2010 Aug:106(3):349-54.  Epub 2010 Jan 19.

Nielsen ME.  Editorial Comment.  J Urol, 2010 Mar:183(3):975.  Epub 2010 Jan 18.

Pruthi RS, Nix J, McRackan D, Hickerson A, Nielsen ME, Raynor M, Wallen EM.  Robotic-assisted laparoscopic intracorporeal urinary diversion.  Eur Urol, 2010 Jun:57(6):1013-21.  Epub 2010 Jan 9.

Pruthi RS, Nielsen ME, Nix J, Smith A, Schultz H, Wallen EM.  Robotic radical cystectomy for bladder cancer:  Surgical and pathological outcomes in 100 consecutive cases.  J Urol, 1010 Feb:183(2):510-4.  Epub 2009 Dec 14.

Smith A, Kurpad R, Lal A, Nielsen ME, Wallen EM, Pruthi RS.  Cost analysis of robotic versus open radical cystectomy for bladder cancer.  J Urol, 2010 Feb:183(2):505-9.  Epub 2009 Dec 14.

Shariat SF, Chade DC, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ, Nielsen ME, et al.  Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer.  J urol, 2010 Jan:183(1):68-75.

Shariat SF, Karakiewicz PI, Godoy G, Karam JA, Ashfaq R, Fradet Y, Isbarn H, Montorsi F, Jeldres C, Bastian PJ, Nielsen ME, et al.  Surviving as a prognostic marker for urothelial carcinoma of the bladder:  a multicenter external validation study.  Clin Cancer Res, 2009 Nov 15:15(22):7012-9.  Epub 2009 Nov 10.

Smith AB, Nielsen ME, Wallen EM, Pruthi RS.  Current status of robot-assisted radical cystectomy.  Curr Opin Urol, 1010 Jan:20(1):60-4.  Review.

Nix J, Smith A, Kurpad, Nielsen ME, Wallen EM, Pruthi RS.  Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer:  Perioperative and pathologic results.  Eur Urol, 1010 Feb:57(2):196-201.  Epub 2009 Oct 20.

Guzzo TJ, Magheli A, Bivalacqua TJ, Nielsen ME, et al.  Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer.  Urology, 2009 Dec:74(6):1276-80.  Epub 2009 Sep 16.

Nielsen ME.  How bad are positive margins after radical prostatectomy and how are they best managed?  J Urol, 2009 Oct:182(4):1257-8.  Epub 2009 Aug 14.

Shariat SF, Bolenz C, Karakiewicz PI, Fradet Y, Ashfaq R, Bastian PJ, Nielsen ME, et. al.  p53 expression in patients with advanced urothelial cancer of the urinary bladder.  BJU Int, 2010 FEb:105(4):489-95.  Epub 2009 Jul 31.

Shariat SF, Lotal Y, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ, Nielsen ME, et al.  p53 predictive value for pT1-2 NO disease at radical cystectomy.  J Urol, 2009 Sep:182(3):907-13.  Epub 2009 Jul 17.

Pruthi RS, Belsante J, Kurpad R, Nielsen ME, Wallen EM.  Urol Oncol, 2011 Jul-Aug:29(4):393-7.  Epub 2009 Jul 3.

Kurpad R, Kim W, Rathmell WK, Godley P, Whang Y, Fielding J, Smith L, Pettiford A, Schultz H, Nielsen ME, Wallen EM, Pruthi RS.  A multidisciplinary approach to the management of urologic malignancies:  Does it influence diagnostic and treatment decisions?  Urol Oncol, 2011 Jul-Aug:29(4)378-82.  Epub 2009 Jul 3.

Margulis V, Lotan Y, Karakiewicz PI, Fradet Y, Ashfaq R, Capitanio U, Montorsi F, Bastian PJ, Nielsen ME, et al.  Multi-institutional external validation of the predictive value of KI-67 labeling index in patients treated with radical cystectomy.  J Natl Cancer Inst, 2009:101(2):114-9.

Nielsen ME, Schaeffer EM, Marschke P, Walsh PC.  High anterior release of the levator fascia improves sexual function following open radical retropubic prostatectomy.  J Urol, 2008 Dec:180(6):2557-64; discussion 2564.  Epub 2008 Oct 19.

Nielsen ME.  Neoadjuvant gemcitabine and cisplatin:  Another step on the path toward improving the outcomes of patients with high-risk, invasive bladder cancer.  Cancer, 2008 Nov 1:113(9):2379-81.

Wu I, Nielsen ME, Han M, Partin AW, Makarov DV.  Does laterality of positive needle biopsy in clinical T2a patients with prostate cancer affect biochemical recurrence-free survival?  Urology, 2008 Dec:72(6):1219-23.  Epub 2008 Apr 18.

Wagner A, Munter M, Makarov D, Nielsen ME, Scorpio D, Kavoussi LR.  Totally laparoscopic creatin of a novel stapled orthotopic neobladder in the procine model.  J Endourol, 2008 Jan:22(1):151-6.

Hernandez DJ, Nielsen ME, Han M, Trock BJ, Partin AW, Walsh PC, Epstein JI.  Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy.  Urology, 2008 Jul:72(1):172-6.  Epub 2008 Mar 4.

Osunkoya AO, Nielsen ME, Epstein JI.  Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy:  A study of 47 cases.  Am J Surg Pathol, 2008 Mar:32(3):468-72.

Nielsen ME, Makarov DV, Humphreys E, Mangold L, Partin AW, Walsh PC.  Is it possible to compare PSA recurrence-free survival after surgery and radiotheapy using revised ASTRO criterion--"nadir+2"?  Urology, 2008 Aug:72(2):389-93; discussion 394-5.  Epub 2008 Feb 15.

Nielsen ME, Lima G, Schaeffer EM, Porter J, Cadeddu JA, Tuerk I, Kavoussi LR.  Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer.  Urology, 2007 Dec:70(6):1168-72.

Nielsen ME, Bastian PJ, Palapattu GS, Trock BJ, Schoenberg MP, Chan T, Rogers CG.  Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.  Urology, 2007 Dec:70(6):1901-5.

Hernandez DJ, Nielsen ME, Han M, Partin AW.  Contemporary evaluation of the D'amico risk classification of prostate cancer.  Urology, 2007 Nov:70(5):931-5.

Muntener M, Schaffer EM, Romero FR, Nielsen ME, et al.  Incidence of local recurrence and port site metastasis after laparoscopic radical nehproureterectomy.  Urology, 2007 Nov:70(5):864-8.

Muntener M, Epstein JI, Hernandez DJ, Gonzalgo ML, Mangold L, Hemphreys E, Walsh PC, Partin AW, Nielsen ME.  Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy.  Eur Urol, 2008 Apr:53(4):767-75; discussion 775-6.  Epub 2007 Nov 20.

Kleeberger W, Bova GS, Nielsen ME, Herawi M, Chuang AY, Epstein JI, Berman DM.  Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis.  Cancer Res, 2007 Oct 1:67(19):9199-206.

Nielsen ME, Palapattu GS, Karakiewicz PI, Lotan Y, Bastian PJ, et al.  A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome.  BJU Int, 2007 Nov:100(5):1015-20.  Epub 2007 Sep 3.

Chuang AY, Nielsen ME, Hernandez DJ, Walsh PC, Epstein JI.  The significance of positive surgical margin in areas of capsular incision in otherwise organ confined disease at radical prostatectomy.  J Urol, 2007 Oct:178(4 Pt 1):1306-10.  Epub 2007 Aug 14.

Nielsen ME, Partin AW.  The impact of definitions of failure on the interpretation of biochemical recurrence following treatment of clincally localized prostate cancer.  Rev Urol, 2007 Spring:9(2):57-62.

Tamas EF, Nielsen ME, Schoenberg MP, Epstein JI.  Lymphoepithelioma-like carcinoma of the urinary tract:  A clinicopathological study of 30 pure and mixed cases.  Mod Pathol, 2007 Aug:20(8):828-34.  Epub 2007 Jun 1.

Muntener M, Schaeffer EM, Nielsen ME, Romero FR, et al.  Rebuttal from authors re:  Peter Albers.  Quality criteria of laparoscpic nephroureterectomy.  Eur Urol, 2007:51:1481-2.  Eur Urol, 2007 Jun:51(6):1482-4.  Epub 2007 Feb 20.

Muntener M, Nielsen ME, et al.  Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma.  Eur Urol, 2007 Jun:51(6):1639-44.  Epub 2007 Jan 16.

Search for additional publications on PubMed using nielsen me as search criteria.